Lushang Freda Pharmaceutical Hits Day Low Amid Price Pressure at CNY 6.38

Lushang Freda Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 5.72% to reach an intraday low of CNY 6.38. This performance marks a stark contrast to the broader market, as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Lushang Freda has seen a decrease of 9.82%, and its one-month performance reflects a decline of 11.55%. Year-to-date, the stock has lost 12.64%, while its performance over the last year shows a decrease of 12.99%. In a longer-term view, the stock has underperformed significantly, with a three-year decline of 38.82% and a five-year drop of 43.6%. The company's financial metrics indicate challenges, including a low return on equity of 5.82% and a high price-to-book ratio of 1.75. Additionally, Lushang Freda has reported negative growth in net sales and operating profit over the past five years, raising concerns about its long-term viability in the realty industry.